The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Central Brain Tumor Registry of the United States
244 E. Ogden Avenue
Hinsdale, IL 60521
The Central Brain Tumor Registry of the United States (CBTRUS) is a voluntary, non-profit organization dedicated to collecting and disseminating statistical data on all primary benign and malignant brain tumors. Such data collection is for the purposes of accurately describing incidence rates and survival patterns, evaluating diagnosis and treatment, facilitating studies concerning causes (etiology), promoting professional and public awareness, and, ultimately, working toward the possible prevention of such brain tumors. CBTRUS was incorporated in 1992 following a two-year study by the American Brain Tumor Association to determine the feasibility of a central registry for all brain tumor cases. Previously, standard data collection in the United States had been limited to malignant brain tumor cases. The CBTRUS database summarizes collaborators' data and generates statistics that are published in the form of an annual report. The annual report is mailed free of charge to over 2,000 members of the neuroscience community as well as to affected individuals, family members, and businesses upon request. In addition to data collection and dissemination, CBTRUS is dedicated to conducting special studies aimed at broadening the scope of data concerning the incidence and prevalence of brain tumors in certain populations. CBTRUS also encourages and promotes interdisciplinary dialogue with other professional and volunteer organizations.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.